ARSA
ARSA (arylsulfatase A, also known as ASA) is a lysosomal sulfatase that hydrolyses cerebroside-3-sulfate into cerebroside and sulfate. Loss of ARSA function is linked to metachromatic leucodystrophy, a progressive demyelinating disease of the nervous system. Browse Assay Genie's current range of ARSA research reagents below, or read on for the biology behind the target.
ARSA is a lysosomal enzyme that catalyses the hydrolysis of cerebroside-3-sulfate (N-acyl-1-beta-D-(3-O-sulfo)-galactosyl-sphing-4-enine) into cerebroside and sulfate. This reaction requires the activator protein saposin B, which presents the lipid substrate to the enzyme. ARSA is also involved in the catabolism of other sulfoglycosphingolipids, including SB1a and SM3 (beta-D-3-sulfogalactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine). By removing the sulfate group from these lipids, the enzyme allows them to be processed further within the lysosome.
The ARSA gene encodes a protein that belongs to the sulfatase family, and HGNC places it in the sulfatases gene group. The enzyme is assigned EC 3.1.6.8 and is annotated by UniProt to the endoplasmic reticulum and the lysosome, consistent with synthesis in the secretory pathway followed by delivery to its site of action. NCBI Gene reports that alternatively spliced transcript variants have been described for the gene, so researchers working with ARSA should consider which transcript or product is relevant to their experiment.
ARSA is best known through its association with disease. According to the NCBI Gene summary, defects in this gene lead to metachromatic leucodystrophy (MLD), a progressive demyelination disease that causes a variety of neurological symptoms and ultimately death. This connection between a single lysosomal hydrolase and myelin pathology makes ARSA a reference example in the study of sulfatide metabolism and lysosomal storage disorders. The enzyme is also known by the alias ASA, which appears in older literature alongside the approved symbol ARSA.
Defects in ARSA lead to metachromatic leucodystrophy, a progressive demyelination disease, making the enzyme central to studies of its mechanism.
ARSA is a lysosomal hydrolase, so it serves as a model for sulfoglycosphingolipid catabolism and the consequences of its failure.
ARSA converts cerebroside-3-sulfate to cerebroside and sulfate, and also acts on sulfoglycosphingolipids such as SB1a and SM3.
Loss of ARSA activity is associated with progressive demyelination and neurological symptoms, linking lipid turnover to nervous system health.
ARSA is a lysosomal enzyme that hydrolyses cerebroside-3-sulfate into cerebroside and sulfate, a reaction that requires the activator protein saposin B. It also contributes to the breakdown of other sulfoglycosphingolipids, including SB1a and SM3.
ARSA stands for arylsulfatase A, and ASA is a recognised alias. The enzyme is classified as EC 3.1.6.8 and belongs to the sulfatase family. NCBI Gene notes that alternatively spliced transcript variants have been described for this gene.
Defects in the ARSA gene lead to metachromatic leucodystrophy (MLD), a progressive demyelination disease. It causes a range of neurological symptoms and ultimately death. Check the datasheet of any product for its validated reactivity before using it in disease models.
Other sulfatases, sphingolipid-metabolism enzymes, saposin pathway partners and lysosomal markers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P15289; product specifications from Assay Genie datasheets.